8-K: Mangoceuticals Restructures Preferred Stock, Establishes Series D

Mangoceuticals, Inc. has amended its Series B and C preferred stock and established a new Series D Preferred Stock, impacting dividend and liquidation rights.

Summary

• Mangoceuticals, Inc. has amended its Series B and Series C preferred stock designations and established a new Series D Preferred Stock, effective November 9, 2026.
• The Series D Preferred Stock ranks senior to common stock regarding dividends and liquidation preferences.
• Each Series D share has a $10.00 stated value and accrues an 8% annual dividend, payable quarterly.
• In liquidation, Series D holders are entitled to $15.00 per share plus accrued dividends.
• Conversion to common stock is permitted after three years, subject to beneficial ownership limits and Nasdaq/stockholder approval requirements.
• The company has filed a Form 1-A for a Regulation A offering related to the Series D Preferred Stock, which is subject to Commission qualification.
• The Series C preferred stock holder approved these changes via written consent, representing 100% of outstanding shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, primarily focused on corporate restructuring and preferred stock designations rather than immediate operational or financial performance changes.

Positives

• Establishment of Series D Preferred Stock with a clear 8% dividend rate and a $15.00 liquidation preference provides a defined structure for a segment of its capital.
• The Series C preferred stock holder, representing 100% of outstanding shares, unanimously approved the amendments and new designation, indicating strong alignment.
• The amendments to Series B and C preferred stock designations waive certain restrictions, potentially facilitating future transactions and capital raises.

Negatives

• The Series D Preferred Stock ranks senior to common stock, potentially diluting common shareholder rights to dividends and liquidation proceeds.
• Conversion to common stock is subject to significant restrictions, including Nasdaq rules and potential stockholder approval, which could delay or prevent conversion.
• The Series D Preferred Stock and associated common stock issuances have not been registered under the Securities Act, limiting immediate trading and requiring future registration or exemption.

Risks

• Potential for future dilution of common stock if Series D Preferred Stock is converted, subject to approval and ownership limitations.
• The company's ability to raise capital through the proposed Regulation A offering is contingent on SEC qualification of its Form 1-A.
• The senior ranking of Series D Preferred Stock in liquidation and dividends could negatively impact common stockholders in adverse scenarios.
• Restrictions imposed by Nasdaq rules and the need for stockholder approval for significant issuances of common stock could impede strategic flexibility.

Future Outlook

The company is proceeding with a Regulation A offering for its Series D Preferred Stock, which is subject to SEC qualification. The conversion price for Series D Preferred Stock into Common Stock will be established upon Commission qualification of the Form 1-A offering statement. The issuance of common stock upon conversion or redemption is subject to Nasdaq rules and potential stockholder approval.

Management Comments

• The Board of Directors approved the Amendments on November 4, 2026.
• The Board of Directors approved the designation of the Series D Preferred Stock on November 9, 2026.

Industry Context

StockSavvy.ai notes that the restructuring of preferred stock and the establishment of new series are common corporate actions, particularly for companies seeking to raise capital or adjust their capital structure. The use of Regulation A for the offering aligns with strategies for smaller companies to access public markets with less stringent registration requirements than a traditional IPO.

Comparison to Industry Standards

• The 8% dividend rate on preferred stock is within the typical range for such instruments, though specific risk profiles of the issuer can influence this.
• A liquidation preference of 1.5x the stated value ($15.00 vs $10.00) is a common feature to provide enhanced security to preferred shareholders.
• The beneficial ownership limitations (4.999% to 9.999%) are standard provisions to manage potential control issues and ensure compliance with certain regulations.
• The aggregate common stock issuance cap (19.99%) is a typical threshold that often triggers the need for stockholder approval under exchange listing rules like Nasdaq's.

Corporate Governance

Stakeholder Impact

• Shareholders: Common stockholders' rights to dividends and liquidation distributions are subordinated to the Series D Preferred Stock. Potential for future dilution exists if Series D is converted.
• Creditors: The Series D Preferred Stock's senior ranking applies among equity holders and is subject to the claims of creditors.
• Investors in Series D Preferred Stock: Benefit from a fixed dividend rate and a liquidation preference, with defined conversion and redemption rights, subject to various conditions.

Next Steps

• The company must obtain SEC qualification for its Form 1-A offering statement to proceed with the Regulation A offering of Series D Preferred Stock.
• The conversion price for Series D Preferred Stock will be established upon Commission qualification of the Form 1-A.
• The company may need to seek stockholder approval to issue common stock upon conversion or redemption if it exceeds Nasdaq's limits.
• The company may redeem outstanding Series D shares beginning on the third anniversary of the first issuance.

Key Dates

Recommendation

The filing primarily concerns corporate restructuring of preferred stock and the initiation of a capital raise process via Regulation A. While the establishment of Series D provides clarity on a portion of the capital structure, it also introduces senior securities that subordinate common equity. The actual impact on share price will depend heavily on the successful qualification and execution of the Regulation A offering and future operational performance, making a 'hold' recommendation prudent pending further developments.

Keywords

Preferred Stock, Series D, Series B, Series C, Capital Structure, Dividend Rights, Liquidation Preference, Regulation A